Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice

References

• Koca SS, Bahcecioglu IH, Poyrazoglu OK, Ozercan IH, Sahin K, Ustundag B. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Inflammation 2008;31:91–8.
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 2008;103:1372–9.
   PubMed Web of Science ®Google Scholar
• Uemura M, Swenson ES, Gaça MD, Giordano FJ, Reiss M, Wells RG. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Biol Cell 2005;16:4214–24.
   PubMed Web of Science ®Google Scholar
• Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 2005;41:1074–84.
   PubMed Web of Science ®Google Scholar
• He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Adipose-specific peroxisome proliferator- activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 2003;100:15712–17.
   PubMed Web of Science ®Google Scholar
• Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000;119:466–78.
   PubMed Web of Science ®Google Scholar
• Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Scand J Gastroenterol 2009;44:358–65.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J, Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro. Int J Biochem Cell Biol 2010;42:948–57.
   PubMedGoogle Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467–2474.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator. Hepatology 2006;43:826–36.
   PubMed Web of Science ®Google Scholar
• Day CP, Saksena S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 2002;17(Suppl 3):S377–84.
   Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998;114:842–5.
   PubMed Web of Science ®Google Scholar
• Nan YM, Wu WJ, Fu N, Liang BL, Wang RQ, Li LX, Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental nonalcoholic steatohepatitis in mice. Scand J Gastroenterol 2009;44:1121–31.
   PubMed Web of Science ®Google Scholar
• Kumagai T, Kawamoto Y, Nakamura Y, Hatayama I, Satoh K, Osawa T, 4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 2000;273:437–41.
   PubMed Web of Science ®Google Scholar
• Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995;96:2461–8.
   PubMed Web of Science ®Google Scholar
• Leclercq IA, Farrell GC, Sempoux C, dela Peña A, Horsmans Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 2004;41:926–34.
   PubMed Web of Science ®Google Scholar
• Beraza N, Malato Y, Vander Borght S, Liedtke C, Wasmuth HE, Dreano M, Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 2008;57:655–63.
   PubMed Web of Science ®Google Scholar
• Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Activation of retinoic X receptor and peroxisome proliferator-activated receptor-γ inhibits nitric oxide and tumor necrosis factor-α production in rat Kupffer cells. Hepatology 2001;33:91–9.
   PubMed Web of Science ®Google Scholar
• Wagstaff AJ, Goa KL. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus. Drugs 2002;62:1805–37.
   PubMed Web of Science ®Google Scholar
• Tahan V, Eren F, Avsar E, Yavuz D, Yuksel M, Emekli E, Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis. Dig Dis Sci 2007;52:3465–72.
   PubMed Web of Science ®Google Scholar
• Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82–6.
   PubMed Web of Science ®Google Scholar
• Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79–82.
   PubMed Web of Science ®Google Scholar
• Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 2004;89:2728–35.
   PubMed Web of Science ®Google Scholar
• Asada K, Sasaki S, Suda T, Chida K, Nakamura H. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med 2004;169:195–200.
   PubMed Web of Science ®Google Scholar
• Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Antidiabetic thiazolidinedions inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002;122:1924–40.
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni G, De Minicis S, Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int 2008;28:1052–64.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247–50.
   PubMed Web of Science ®Google Scholar
• Gressner OA, Lahme B, Demirci I, Gressner AM, Weiskirchen R. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 2007;47:699–710.
   PubMed Web of Science ®Google Scholar
• Paradis V, Dargere D, Bonvoust F, Vidaud M, Segarini P, Bedossa P. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 2002;82:767–74.
   PubMed Web of Science ®Google Scholar
• Corcoran ML, Hewitt R, Kleiner DE Jr, Stetler-Stevenson WG. MMP-2: expression, activation and inhibition. Enzyme Protein 1996;49:7–19.
   PubMedGoogle Scholar
• Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007;46:955–75.
   PubMed Web of Science ®Google Scholar
• Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 2004;40:177–84.
   PubMed Web of Science ®Google Scholar
• Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Hepatic adipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology 2008;48:458–73.
   PubMed Web of Science ®Google Scholar
• Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 2005;166:1655–69.
   PubMed Web of Science ®Google Scholar
• Wu CW, Chu ES, Lam CN, Cheng AS, Lee CW, Wong VW, PPARgamma is essential for protection against nonalcoholic steatohepatitis. Gene Ther 2010;17:790–8.
   PubMedGoogle Scholar
• Mandal P, Pritchard MT, Nagy LE. Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway. World J Gastroenterol 2010;16:1330–6.
   PubMed Web of Science ®Google Scholar
• Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A, Cook JA. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta-(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 2003;171:6827–37.
   PubMed Web of Science ®Google Scholar
• Li M, Li Z, Sun X, Yang L, Fang P, Liu Y, Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells. FEBS J 2010;277:1543–50.
   PubMedGoogle Scholar
• Kitamura Y, Kakimura J, Matsuoka Y, Nomura Y, Gebicke-Haerter PJ, Taniguchi T. Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. Neurosci Lett 1999;262:129–32.
   PubMed Web of Science ®Google Scholar
• Yu J, Chu ES, Wang R, Wang S, Wu CW, Wong VW, Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice. Gastroenterology 2010;138:694–704.
   PubMedGoogle Scholar
• Li L, Grenard P, Nhieu JT, Julien B, Mallat A, Habib A, Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Gastroenterology 2003;125:460–9.
   PubMed Web of Science ®Google Scholar